Category Archives: E-Media

Lilly Launches Online Training for Patient Advocates

An interactive training program designed “to help patient advocates better influence decisions related to access to new medicines” was launched today by Eli Lilly.
Also posted in Europe, Technology | Tagged , , , | Leave a comment

Europe: EFPIA Campaign Calls for Integrated Life Sciences Strategy

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign calling for an integrated life sciences  strategy for the EU. The #HealthyEU Health and Growth campaign will outline the opportunities and threats faced by patients and the healthcare sector today, and provide evidence and facts to inform healthcare debates in the run […]
Also posted in Europe, Events, Global, multimedia, Regulatory, social media, Strategy | Tagged , , , , , | Leave a comment

Unlock The True Value of Digital Communication: Knowledge, Motivation, Context

By Morten Hjelmsoe. Interaction between pharma representatives and doctors has traditionally been a paper-based and static experience in which the representative enters with one-quarter of a campaign in hand and then tries to deliver the remaining pieces three more times through the year, losing any momentum created during that initial visit. But to be effective […]
Also posted in Marketing, multimedia, Op-Ed, Technology | Tagged , , | Leave a comment

New Faces of Patient Advocacy

In this short video, Brianna Cayo-Cotter, Change.org’s managing director of communications, talks to Pharm Exec about how advocacy organizations and individual patients are getting more involved in every facet of the healthcare system, from drug R&D, to federal and state policy, all fueled by the hour-to-hour passion of living with a disease.
Also posted in healthcare, patient education, People, social media, Video | Tagged , , | Leave a comment

FDA Guidances, OIG Investigations to Shape Drug Marketing, Research

Marketers may see further advice from the Food and Drug Administration in the coming year that clarifies how they can use social media. Priority topics:  presenting risk and benefit information in limited space; correcting independent/third party misinformation about a drug or medical device; and appropriate use of links, according to the agenda for the Center […]
Also posted in Advertising, Biotech, FDA, Legal, pricing, Regulatory, social media | Tagged , , , , , , , | Leave a comment
  • Categories

  • Meta